The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Open accessAbstract
Alpha‐synucleinopathies (ASP) are neurodegenerative disorders, characterized by accumulation of misfolded α‐synuclein, selective neuronal loss, and extensive gliosis. It is accepted that microgliosis and astrogliosis contribute to the disease progression in ASP. Toll‐like receptors (TLRs) are expressed on cells of the innate immune system, including glia, and TLR4 dysregulation may play a role in ASP pathogenesis. In this study we aimed to define the involvement of TLR4 in microglial and astroglial activation induced by different forms of α‐synuclein (full length soluble, fibrillized, and C‐terminally truncated). Purified primary wild type (TLR4+/+) and TLR4 deficient (TLR4−/−) murine microglial and astroglial cell cultures were treated with recombinant α‐synuclein and phagocytic activity, NFκB nuclear translocation, cytokine release, and reactive oxygen species (ROS) production were measured. We show that TLR4 mediates α‐synuclein‐induced microglial phagocytic activity, pro‐inflammatory cytokine release, and ROS production. TLR4−/− astroglia present a suppressed pro‐inflammatory response and decreased ROS production triggered by α‐synuclein treatment. However, the uptake of α‐synuclein by primary astroglia is not dependent on TLR4 expression. Our results indicate the C‐terminally truncated form as the most potent inductor of TLR4‐dependent glial activation. The current findings suggest that TLR4 plays a modulatory role on glial pro‐inflammatory responses and ROS production triggered by α‐synuclein. In contrast to microglia, the uptake of alpha‐synuclein by astroglia is not dependent on TLR4. Our data provide novel insights into the mechanisms of α‐synuclein‐induced microglial and astroglial activation which may have an impact on understanding the pathogenesis of ASP. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous reports showed α-synuclein can trigger TLR4 or TLR2 activation in cultured glia, which leads to an increase in inflammatory gene transcription19,40,41.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [40]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“TLR4 was required for NF-κB activation, and increased inflammation and phagocytic activity in response to various forms of α-synuclein40,41,56.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“TLR4 was required for NF-κB activation, and increased inflammation and phagocytic activity in response to various forms of α-synuclein40,41,56.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“TLR4 was required for NF-κB activation, and increased inflammation and phagocytic activity in response to various forms of α-synuclein40,41,56.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“For instance, α -synuclein aggregates induce microglial activation (Boza-Serrano et al., 2014) in a TLR-4 dependent manner (Fellner et al., 2013).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Fellner et al., 2013
In the citing paper
“Oligomeric α-syn directly engages TLR1/2 and TLR4 to induce a pro-inflammatory M1 phenotype.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [246]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200
Broad Expression of Toll-Like Receptors in the Human Central Nervous System
Bsibsi, M., Ravid, R., Gveric, D. O., & van Noort, J. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.11.1013 · Cited by 1,000
Saijo, K., Winner, B., Carson, C. T., Collier, J. G., Boyer, L., Rosenfeld, M. G., Gage, F. H., & Glass, C. K. (2009) · Cell · doi:10.1016/j.cell.2009.01.038 · Cited by 957
Microglia as neuroprotective, immunocompetent cells of the CNS
Streit, W. J. (2002) · Glia · doi:10.1002/glia.10154 · Cited by 919
Lee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877
Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786
The role of microglia and macrophages in the pathophysiology of the CNS
Stollg, G., & Jander, S. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00083-5 · Cited by 683
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 699
Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight
Forloni, G., Vitola, P. L., Cerovic, M., & Balducci, C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.11.001 · Cited by 41
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
Du, T., Wang, L., Liu, W., Zhu, G., Chen, Y., & Zhang, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.645996 · Cited by 41
Extracellular alpha-synuclein: Sensors, receptors, and responses
Domingues, R., Sant’Anna, R., da Fonseca, A. C. C., Robbs, B. K., Foguel, D., & Outeiro, T. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105696 · Cited by 38
Toll-like receptor 4 signaling: A common biological mechanism of regimen-related toxicities
Wardill, H. R., Sebille, Y. Z. A. V., Mander, K. A., Gibson, R. J., Logan, R. M., Bowen, J. M., & Sonis, S. T. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.11.005 · Cited by 37
A secret that underlies Parkinson's disease: The damaging cycle
Sun, F., Deng, Y., Han, X., Liu, Q., Zhang, P., Manzoor, R., & Ma, H. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104484 · Cited by 37
Juul‐Madsen, K., Qvist, P., Bendtsen, K. L., Langkilde, A. E., Vestergaard, B., Howard, K. A., Dehesa-Etxebeste, M., Paludan, S. R., Andersen, G. R., Jensen, P. H., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900494 · Cited by 37
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Jung, Y. J., Tweedie, D., Scerba, M. T., Kim, D. S., Palmas, M. F., Pisanu, A., Carta, A. R., & Greig, N. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656921 · Cited by 37
NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases
Boonpraman, N., & Yi, S. S. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390973 · Cited by 37
Miao, Y., & Meng, H. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01402-y · Cited by 40
Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson’s disease
Chi, X., Yin, S., Sun, Y., Kou, L., Zou, W., Wang, Y., Jin, Z., Wang, T., & Xia, Y. F. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.022 · Cited by 42
Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases
Kuštrimović, N. Z., Balkhi, S., Bilato, G., & Mortara, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212164 · Cited by 39
Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes
Wong, C.-O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145149 · Cited by 31
He, S., Zhong, S., Liu, G., & Yang, J. (2020) · Neurodegenerative Diseases · doi:10.1159/000511083 · Cited by 36
Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease
Su, R., & Zhou, T. G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.769506 · Cited by 38
Immune-related biomarkers for Parkinson's disease
Abdi, I. Y., Ghanem, S. S., & El‐Agnaf, O. M. A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105771 · Cited by 38
Thangaleela, S., Sivamaruthi, B. S., Kesika, P., Bharathi, M., & Chaiyasut, C. (2022) · Microorganisms · doi:10.3390/microorganisms10081544 · Cited by 37
Lobenwein, D., Gollmann‐Tepeköylü, C., Kozaryn, R., Pechriggl, E. J., Bitsche, M., Graber, M., Fritsch, H., Semsroth, S., Stefanova, N., Paulus, P., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002440 · Cited by 36
Self-citationNeuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
van Wetering, J., Geut, H., Bol, J. G. J. M., Galis, Y., Timmermans, E., Twisk, J. W. R., Hepp, D. H., Morella, M. L., Pihlstrøm, L., Lemstra, A. W., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01786-z · Cited by 41
Anti-Inflammatory and Neuroprotective Effects of PGE2 EP4 Signaling in Models of Parkinson’s Disease
Pradhan, S., Salinas, K. J., Garduno, A. C., Johansson, J. U., Wang, Q., Manning-Bog, A., & Andreasson, K. I. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9713-6 · Cited by 36
Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
Kwon, S., Iba, M., Masliah, E., & Kim, C. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.5.547 · Cited by 35
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36
Impact of sex on neuroimmune contributions to Parkinson’s disease
Bourque, M., Morissette, M., Soulet, D., & Paolo, T. D. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110668 · Cited by 36
Harackiewicz, O., & Grembecka, B. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2311203 · Cited by 39
α‐Synuclein in Parkinson's Disease: From Bench to Bedside
Bellini, G., D’Antongiovanni, V., Palermo, G., Antonioli, L., Fornai, M., Ceravolo, R., Bernardini, N., Derkinderen, P., & Pellegrini, C. (2024) · Medicinal Research Reviews · doi:10.1002/med.22091 · Cited by 42
Mariucci, G., Pagiotti, R., Galli, F., Romani, L. R., & Conte, C. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1057-7 · Cited by 34
Kallab, M., Herrera-Vaquero, M., Johannesson, M., Eriksson, F., Sigvardson, J., Poewe, W. H., Wenning, G. K., Nordström, E. K. L., & Stefanova, N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00452 · Cited by 35
Self-citationLee, J., Kim, S. W., & Kim, K.-T. (2022) · Cells · doi:10.3390/cells11121902 · Cited by 34
Boi, L., Pisanu, A., Palmas, M. F., Fusco, G., Carboni, E., Casu, M. A., Satta, V., Scherma, M., Janda, E., Mocci, I., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228535 · Cited by 33
Jiang, T., Xu, S., Shen, Y., Xu, Y., & Li, Y. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s304336 · Cited by 34
Autophagy in α-Synucleinopathies—An Overstrained System
Fellner, L., Gabassi, E., Haybaeck, J., & Edenhofer, F. (2021) · Cells · doi:10.3390/cells10113143 · Cited by 36
Self-citationPericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress
Stevenson, T. J., Johnson, R. H., Savistchenko, J., Rustenhoven, J., Woolf, Z., Smyth, L. C. D., Murray, H. C., Faull, R. L. M., Correia, J. A., Schweder, P. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20261-0 · Cited by 34
Role of mtDNA disturbances in the pathogenesis of Alzheimer’s and Parkinson’s disease
Antonyová, V., Kejík, Z., Brogyányi, T., Kaplánek, R., Pajková, M., Talianová, V., Hromádka, R., Masařík, M., Sýkora, D., Mikšátková, L., et al. (2020) · DNA Repair · doi:10.1016/j.dnarep.2020.102871 · Cited by 45
Pramotton, F. M., Spitz, S., & Kamm, R. D. (2024) · Advanced Science · doi:10.1002/advs.202403892 · Cited by 33
Gut–Brain Axis: Focus on Neurodegeneration and Mast Cells
Conte, C., Sichetti, M., & Traina, G. (2020) · Applied Sciences · doi:10.3390/app10051828 · Cited by 33
Gut Microbiota and Disorders of the Central Nervous System
Vuotto, C., Battistini, L., Caltagirone, C., & Borsellino, G. (2020) · The Neuroscientist · doi:10.1177/1073858420918826 · Cited by 37
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
Lai, T. T., Kim, Y. J., Ma, H.-I., & Kim, Y. E. (2022) · Journal of Movement Disorders · doi:10.14802/jmd.21078 · Cited by 32
Miller, S., Campbell, C. E., Jimenez-Corea, H. A., Wu, G., & Logan, R. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.824191 · Cited by 34
Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
Wang, Z., Wang, Q., Li, S., Li, X.-J., Yang, W., & He, D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1065183 · Cited by 35
Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease
Wang, Y., Xia, Y. F., Kou, L., Yin, S., Chi, X., Li, J., Sun, Y., Wu, J., Zhou, Q., Zou, W., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106224 · Cited by 33
Katzdobler, S., Nübling, G., Klietz, M., Fietzek, U. M., Palleis, C., Bernhardt, A. M., Wegner, F., Huber, M. K., Rogozinski, S., Schneider, L., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12647-z · Cited by 32
Parkinson's disease as a member of Prion-like disorders
Herva, M. E., & Spillantini, M. G. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.016 · Cited by 33
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications
Kuter, K. Z., Cenci, M. A., & Carta, A. R. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.02.004 · Cited by 31
Mitochondrial Dynamics and Bioenergetic Alteration During Inflammatory Activation of Astrocytes
Rahman, M. H., & Suk, K. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.614410 · Cited by 33
Venezia, S., Kaufmann, W. A., Wenning, G. K., & Stefanova, N. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.09.007 · Cited by 31
Self-citationSîrbulescu, R. F., Mamidi, A., Chan, S. C., Jin, G., Boukhali, M., Sobell, D., Ilieş, I., Chung, J. Y., Haas, W., Whalen, M. J., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202101095rr · Cited by 31
Conte, C., Ingrassia, A. M. T., Brevé, J. J. P., Bol, J. G. J. M., Huisman, E., van Dam, A., Beccari, T., & van de Berg, W. D. J. (2023) · Cells · doi:10.3390/cells12101368 · Cited by 33
Caspases orchestrate microglia instrumental functions
Shen, X., Venero, J. L., Joseph, B., & Burguillos, M. Á. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.09.007 · Cited by 31
Astrocytes: From the Physiology to the Disease
Trujillo‐Estrada, L., Gómez-Arboledas, Á., Forner, S., Martini, A. C., Gutiérrez, A., Baglietto‐Vargas, D., & LaFerla, F. M. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190830110152 · Cited by 30
Lai, X., Xiong, Y., Zhou, J., Yang, F., Peng, J., Chen, L., & Zhong, W. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.057 · Cited by 30
Models of multiple system atrophy
Lee, H.-J., Ricarte, D., Ortiz, D. M., & Lee, S. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0346-8 · Cited by 33
Signs of early cellular dysfunction in multiple system atrophy
Herrera-Vaquero, M., Heras‐Garvin, A., Krismer, F., Deleanu, R., Boesch, S., Wenning, G. K., & Stefanova, N. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12661 · Cited by 27
Self-citationInflammation in Experimental Models of α ‐Synucleinopathies
Harms, A. S., Kordower, J. H., Sette, A., Arlehamn, C. S. L., Sulzer, D., & Mach, R. H. (2020) · Movement Disorders · doi:10.1002/mds.28264 · Cited by 31
The Role of Glial Mitochondria in α-Synuclein Toxicity
Jeon, Y., Kwon, Y., Jo, M., Lee, S., Kim, S., & Kim, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.548283 · Cited by 31
Wenzel, T. J., Ranger, A. L., McRae, S. A., & Klegeris, A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577496 · Cited by 29
Wallin, J., & Svenningsson, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115606 · Cited by 29
Papendorf, J. J., Krüger, E., & Ebstein, F. (2022) · Cells · doi:10.3390/cells11091422 · Cited by 34
Understanding the Role of Innate Immunity in the Response to Intracortical Microelectrodes
Hermann, J. K., & Capadona, J. R. (2018) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.2018027166 · Cited by 31
Torres, A., Michea, M. A., Végvári, Á., Arce, M., Pérez, V., Alcota, M., Morales, A., Vernal, R., Budini, M., Zubarev, R. A., et al. (2024) · International Journal of Oral Science · doi:10.1038/s41368-024-00306-y · Cited by 38
Kouroupi, G., Antoniou, N., Prodromidou, K., Taoufik, E., & Matsas, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197113 · Cited by 30
Lee, S., Jeon, Y., Jo, M., & Kim, H. (2021) · Experimental Neurobiology · doi:10.5607/en21021 · Cited by 29
Schafferer, S., Khurana, R., Refolo, V., Venezia, S., Sturm, E., Piatti, P., Hechenberger, C., Hackl, H., Kessler, R., Willi, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150705 · Cited by 29
Self-citationFrom Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
Heras‐Garvin, A., & Stefanova, N. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.584536 · Cited by 31
Self-citationNeuroimmune disruptions from naturally occurring levels of mycotoxins
Shahba, S., Mehrzad, J., & Malvandi, A. M. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14146-4 · Cited by 29
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Soares, É. N., Costa, A. C. D. S., Ferrolho, G. D. J., Ureshino, R. P., Getachew, B., Costa, S. L., da Silva, V. D. A., & Tizabi, Y. (2024) · Cells · doi:10.3390/cells13060474 · Cited by 28
Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells
Liu, G., Guo, J. F., Liu, J., Wang, Z., & Liang, D. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.07.006 · Cited by 29
Brezić, N., Gligorevic, S., Sič, A., & Knežević, N. N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040259 · Cited by 31
Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies
Lim, S., Kim, H., Kim, D., & Lee, S. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.010 · Cited by 28
Cellular Biology of Tau Diversity and Pathogenic Conformers
Kang, S., Eskandari‐Sedighi, G., Hromádková, L., Safar, J., & Westaway, D. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590199 · Cited by 29
ATH434 Reduces α‐Synuclein‐Related Neurodegeneration in a Murine Model of Multiple System Atrophy
Heras‐Garvin, A., Refolo, V., Schmidt, C., Malfertheiner, K., Wenning, G. K., BRADBURY, M. J., Stamler, D. A., & Stefanova, N. (2021) · Movement Disorders · doi:10.1002/mds.28714 · Cited by 28
Self-citationMicroglial activation in Alzheimer's disease: The role of flavonoids and microRNAs
Medrano-Jiménez, E., Meza‐Sosa, K. F., Aragon, J. A. U., Secundino, I., Pedraza-Alva, G., & Pérez-Martínez, L. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr1021-531r · Cited by 28
Chung, L. Y.-R., Lin, Y., Liu, C., Tai, Y., Lin, H., Lin, C., & Chen, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.845930 · Cited by 30
Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments
Chelpin, M. V. E., & Vorup‐Jensen, T. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12542 · Cited by 27
New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
Tan, J. S. Y., Chao, Y., Rötzschke, O., & Tan, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239302 · Cited by 27
Gąssowska-Dobrowolska, M., Olech-Kochańczyk, G., Culmsee, C., & Adamczyk, A. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s468609 · Cited by 29
Multiple System Atrophy: Pathology, Pathogenesis, and Path Forward
Ndayisaba, A., Halliday, G. M., & Khurana, V. (2024) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-104528 · Cited by 31
Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds
Madsen, H. B., & Vilhardt, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010227 · Cited by 26
Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson’s Disease
Gu, C., Chen, Y., Chen, Y., Liu, C., Zhu, Z., & Wang, M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.768156 · Cited by 26
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
Abdelmoaty, M. M., Machhi, J., Yeapuri, P., Shahjin, F., Kumar, V. S., Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.958 · Cited by 25
A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology
Prunell, G., & Olivera‐Bravo, S. (2022) · Biomolecules · doi:10.3390/biom12121745 · Cited by 27
Let’s make microglia great again in neurodegenerative disorders
Guillot‐Sestier, M., & Town, T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1792-x · Cited by 26
Carta, A. R., Boi, L., Pisanu, A., Palmas, M. F., Carboni, E., & Simone, A. D. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108685 · Cited by 27
Is Targeting the Inflammasome a Way Forward for Neuroscience Drug Discovery?
Swanton, T., Cook, J., Beswick, J. A., Freeman, S., Lawrence, C. B., & Brough, D. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218786210 · Cited by 26
An, H., Heo, J. Y., Lee, C. J., & Nam, M. (2021) · Experimental Neurobiology · doi:10.5607/en21007 · Cited by 25
Sequence-dependent Internalization of Aggregating Peptides
Couceiro, J. R., Gallardo, R. U., Smet, F. D., Baets, G. D., Baatsen, P., Annaert, W. G., Roose, K., Saelens, X., Schymkowitz, J. W. H., & Rousseau, F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.586636 · Cited by 27
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24
Rissardo, J. P., McGarry, A. J., Shi, Y., Caprara, A. L. F., & Kannarkat, G. T. (2025) · Brain Sciences · doi:10.3390/brainsci15121260 · Cited by 38
Sinha, S., Mittal, S., & Roy, R. (2021) · Journal of Movement Disorders · doi:10.14802/jmd.21046 · Cited by 25
The role of astrocytes in prion-like mechanisms of neurodegeneration
Smethurst, P., Franklin, H., Clarke, B. E., Sidle, K. C. L., & Patani, R. (2021) · Brain · doi:10.1093/brain/awab366 · Cited by 25
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
Sidoroff, V., Bower, P., Stefanova, N., Fanciulli, A., Stankovic, I., Poewe, W. H., Seppi, K., Wenning, G. K., & Krismer, F. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223183 · Cited by 24
Self-citationDopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Mancini, M., Natoli, S., Gardoni, F., Luca, M. D., & Pisani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065618 · Cited by 24
Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor α-mediated neurotoxicity
Ho, D. H., Seol, W., Eun, J. H., & Son, I. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.163 · Cited by 25
Michalska, P., Buendía, I., Duarte, P., Fernández‐Mendívil, C., Negredo, P., Cuadrado, A., López, M. G., & Leon, R. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104597 · Cited by 25
Doroszkiewicz, J., Winkel, I., & Mroczko, B. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1579511 · Cited by 26
Emerging preclinical pharmacological targets for Parkinson's disease
More, S. V., & Choi, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8104 · Cited by 24
Ye, H., Yang, B., Chen, Q., Zhang, J., Hu, J., & Fan, Y. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00507 · Cited by 23
Myeloid cells in retinal and brain degeneration
Guo, M., Schwartz, T. D., Dunaief, J. L., & Cui, Q. N. (2021) · FEBS Journal · doi:10.1111/febs.16177 · Cited by 25
Francelle, L., & Mazzulli, J. R. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147798 · Cited by 23
Hull, A. J., Atilano, M. L., Gergi, L., & Kinghorn, K. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0381 · Cited by 24
Li, H., Qian, J., Wang, Y., Wang, J., Mi, X., Qu, L., Song, N., & Xie, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102288 · Cited by 22
Hermann, J. K., Lin, S., Soffer, A., Wong, C., Ali, A., Chang, J. B., Sunil, S., Sudhakar, S., Tomaszewski, W. H., Protasiewicz, G., et al. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00113 · Cited by 23
Metadata
- Authors
- Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N.
- Affiliations
- Innsbruck Medical University (AT)
- Corresponding author
- Stefanova, Nadia
- ORCID
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2012-10-25
- Volume
- 61
- Issue
- 3
- Pages
- 349-360
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- PMC
- PMC3568908
- OpenAlex
- W2019863741
- Cited by
- 697
- References
- 64
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 80 · 2023: 54 · 2022: 59 · 2021: 89 · 2020: 79 · 2019: 54 · 2018: 53 · 2017: 42 · 2016: 31 · 2015: 34 · 2014: 31 · 2013: 14
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Glia (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Austrian Science Fund (F4404, P19989)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TLR4, alpha-synuclein, synucleinopathies, microglial activation, astroglial activation, microglial phagocytosis, reactive oxygen species, inflammatory cytokines, NF-κB nuclear translocation, glial activation, neuroinflammation
- MeSH terms
- Animals, Astrocytes, Cells, Cultured, Gliosis, Inflammation, Phagocytosis, Tumor Necrosis Factor-alpha, Interleukin-6, NF-kappa B, Reactive Oxygen Species, Microglia, Mice, Knockout, Protein Transport, Toll-Like Receptor 4, Mice, alpha-Synuclein, Chemokine CXCL1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
